- Germany speeds up access to advanced therapies
- China’s draft patent linkage system
- Australia reclassified active medical device for therapy
- NICE encourages patients to have bigger input in choice of care
MFN Policy Is Moving — Join the Conversation (Part II)
US Most Favoured Nation (MFN) policy continues to evolve.
Join our complimentary 30-minute Office Hours session to explore the latest developments and what they could mean for pricing, launch sequencing and global strategy.
Hosted by Paul Craddy & Nicole Lodowski
